11 Jun 2025 07:30 CEST

Issuer

ORKLA ASA

As previously stated, including in connection with the Capital's Market Update
on 28 May 2025, Orkla has been evaluating various structural options for Orkla
India Limited ("Orkla India") to unlock value, including accessing the Indian
capital markets.

As a part of this process, Orkla India filed a draft red herring prospectus
dated 10 June, 2025 (the "DRHP") with the Indian capital markets regulator,
the Securities and Exchange Board of India ("SEBI"); and BSE Limited and the
National Stock Exchange of India Limited (together, the "Indian Stock
Exchanges") in connection with the proposed initial public offering of equity
shares of face value INR 1 each (the "Equity Shares", and the initial public
offering by Orkla India as the "Offer").

The Offer, as described in the DRHP, would comprise an offer for sale of up
to 22,843,004 Equity Shares ("Offered Shares"), proposed to be undertaken by
Orkla Asia Pacific Pte. Ltd., an indirect wholly owned subsidiary of Orkla
ASA, and other eligible shareholders of Orkla India. Orkla Asia Pacific Pte.
Ltd. intends to offer up to 20,560,768 Equity Shares, representing
approximately 90% of the total number of Offered Shares. The Offered Shares
constitute approximately 16.68% of the total number of the issued, subscribed
and paid-up share capital of Orkla India.

The Offer is subject to receipt of necessary approvals, including from SEBI,
the Indian Stock Exchanges, and the registrar of companies. Following the
receipt of requisite approvals, the Offer will be launched within the
timelines permitted by law, subject to market conditions and other
considerations.

The DRHP is available on the website of Orkla India at
https://www.orklaindia.com (https://www.orklaindia.com/).

Orkla ASA
Oslo, 11 June 2025

Ref.:

SVP Investor Relations
Annie Bersagel
Tel.: +47 986 03 664

This information is subject to disclosure requirements set out in the
Norwegian Securities Trading Act Section 5-12.

DISCLAIMER

Not for distribution in the United States of America, Canada, Australia or
Japan or in any other jurisdiction in which such distribution or dissemination
would be prohibited by applicable law.

This notice is not being made available in, and is not for release,
publication or distribution, directly or indirectly, in whole or in part, in
or into the United States of America, Canada, Australia or Japan or any other
jurisdiction in which such distribution or dissemination would be prohibited
by applicable law. This announcement is for informational purposes only and is
not intended, and should not be construed, as an offer of, or a solicitation
of an offer to buy, securities in the United States or any other jurisdiction.
The securities described herein have not been and will not be registered under
the United States Securities Act of 1933 (the U.S. Securities Act), or the
laws of any state of the United States, and may not be offered or sold within
the United States, except pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the U.S. Securities Act and
in compliance with all applicable state laws. There will be no public offering
of such securities in the United States.


Source

Orkla ASA

Provider

Oslo Børs Newspoint

Company Name

ORKLA, Orkla ASA 16/26 2,35%, Orkla ASA 21/31 2,4425pct, Orkla ASA 21/27 FRN, Orkla ASA 21/29 2,20pct, Orkla ASA 23/30 4,405%, Orkla ASA 23/28 FRN

ISIN

NO0003733800, NO0010774391, NO0011013716, NO0011095499, NO0011095507, NO0012862780, NO0012862772

Symbol

ORK

Market

Euronext Oslo Børs